BREAKING: FDA & CDC Recommend Halt to J & J Vaccine Due to Blood Clots in Women

Just several weeks after Governor Phil Murphy came to an apartment complex in Union City along with New Jersey Commissioner of Heath Judith Persichilli and the CEO of Johnson and Johnson to tout the third COVID vaccine to hit the market, this morning both the Federal Drug Administration and the Centers For Disease Control have recommended that the J&J vaccine stop being used after a half dozen women developed blood clots after receiving the one dose vaccine.

The news certainly is not good, as more and more Americans continue to get vaccinated and the country is seeing a spike once again in the number of COVID cases nationwide.

According to the FDA, the CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday to further review these cases and assess their potential significance.

Meanwhile, the FDA and the CDC issued the following joint statement today:

“Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution.  This is important, in part, to ensure that the health care provider community is aware of the potential for these adverse events and can plan for proper recognition and management due to the unique treatment required with this type of blood clot.”

It took about two weeks following their vaccination with the Johnson & Johnson vaccine for the women to develop the blood clots.  All six recipients were women between the ages of 18 and 48.  One woman died and a second woman in Nebraska has been hospitalized in critical condition.

According to data released by the CDC, nearly seven million people in the United States have received Johnson & Johnson shots so far, and roughly nine million more doses have been shipped out to the states.

While this morning’s announcement was targeted as a recommendation to state health practitioners, the federal government is expected to pause the administration of the vaccine at all federally run vaccination sites. Federal officials expect that state health officials will see that move as a strong signal for them to do the same.

There’s no word yet from Governor Murphy’s office on what will happen here in New Jersey.